ホンジュラス特有の花粉アレルギー市場 – 業界動向と2029年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ホンジュラス特有の花粉アレルギー市場 – 業界動向と2029年までの予測

  • Pharmaceutical
  • Published Report
  • Sep 2022
  • Country Level
  • 350 ページ
  • テーブル数: 21
  • 図の数: 19

ホンジュラス特有の花粉アレルギー市場、薬剤タイプ別(抗ヒスタミン薬、充血除去薬、コルチコステロイド、抗コリン薬など)、診断テスト(生体内テストおよび生体外テスト)、製品(機器、試薬、キットなど)、エンドユーザー(病院、診断研究所、学術研究機関など)、流通チャネル(直接入札および小売販売) - 2029年までの業界動向と予測。

ホンジュラス特有の花粉アレルギー市場の分析と洞察

ホンジュラス特有の花粉アレルギー市場は、花粉アレルギー反応の有病率の高さ、アレルギーと闘うさまざまな先進療法を伴うホンジュラスでの新薬承認の増加などの要因によって推進されており、市場の成長を牽引しています。花粉の空中アレルゲンは市場の機会として機能し、市場を推進する可能性があります。小児人口への影響は、環境条件、土壌の使用の変化、さまざまな花粉シーズン、および治療計画に関するアレルギー専門医の年間データによって異なります。現在、医療費の増加と医薬品市場の成長も市場の成長を推進すると予想されています。アレルギー疾患の有病率は増加しており、診断、治療、および患者間の意識向上のための統合された方法が必要です。膨大な人口がアレルギー疾患に苦しんでおり、大きな負担を生み出しています。アレルギー症例の増加は治療の需要を増加させ、予測期間中の市場の高成長につながると予想されます。

ホンジュラス特有の花粉アレルギー市場

ホンジュラス特有の花粉アレルギー市場

ホンジュラス市場は、市場プレーヤーの増加と新薬の存在により、予測期間中に成長すると予想されています。これに伴い、メーカーは市場に新製品を投入するための研究開発活動に取り組んでいます。研究開発プログラム数の増加、革新的で効果的な治療のための新開発を促進するための官民パートナーシップの増加は、市場にさらなる影響を与えます。ただし、市場で使用される薬物の副作用とステロイド薬の誤用は、予測期間中の市場成長を抑制すると予想されます。ただし、治療費が高いため、患者は高品質で効果的なソリューションを受け入れることが制限されます。今後、治療手順の高コストは、全体的な治療費に悪影響を及ぼします。

Honduras specific pollen allergies market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for safe distribution of machine and drugs products are the major drivers which propelled the demand of the market in the forecast period.

Honduras specific pollen allergies market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Honduras specific pollen allergies market will grow at a CAGR of 5.7% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Drug Type (Antihistamines, Decongestants, Corticosteroids, Anticholinergics and Others), Diagnostic Test (In Vivo Test and In Vitro Test), Product (Instruments, Reagents and Kits and Others), End User (Hospitals, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales) 

Countries Covered

 Honduras

Market Players Covered

Siemens Healthcare GmbH, Sanofi, bioMérieux SA, GlaxoSmithKline plc., Minaris Medical America, Inc., Quest Diagnostics Incorporated, Circassia, Alcon Inc., Thermo Fisher Scientific Inc., Johnson & Johnson SA de CV, Lincoln Diagnostics, Inc., EUROIMMUN Medizinische Labordiagnostika AG, Bayer Pharmaceuticals, Prestige Consumer Healthcare Inc., CINFA LABORATORIES, Perrigo Company plc., among others.

Market Definition

Allergic diseases are the immunological response of the body to a particulate matter when it invades the body. These include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling. These pollens (typically weed pollens) are easily found in the atmosphere in the spring season as well as grass pollens in the summer. Most of the pollen that causes allergic reactions comes from trees, grasses, and weeds. These plants make small, light, and dry pollen grains that travel by air. These are easily found everywhere. Since, it is difficult to completely avoid allergens and therefore, it is crucial to accurately identify the causative antigen for rapid diagnosis and prompt initiation of treatment of allergen immunotherapy. Pollen counts are generally taken with an air-sampling device.

The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients. A vast population is suffering from allergic diseases that have generated a significant burden. Rising cases of allergies are expected to increase the demand for treatment, leading to the high growth of the market over the forecast period.

Honduras Specific Pollen Allergies Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of these are discussed in detail below:

Drivers

  • Increasing prevalence of allergic disorder

The hypersensitive response of the immune system of an allergic individual to a substance is known as allergic reaction. When an allergen enters the body, it causes the body's immune system to develop an allergic reaction. This reaction can occur when the immune system attacks a normally harmless substance. This can happen in any age, but more frequent in younger age due to the proper functioning of immune response.

Different individuals can be allergic to various allergens, such as pollens allergies among others, which are some of the common allergic reactions. The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients. A vast population is suffering from allergic diseases that have generated a significant burden. Rising cases of allergies are expected to increase the demand for treatment, leading to the high growth of the market over the forecast period.

The retrospective studies and recent data on the allergies shows that it is a common disorder in Latin and Central America. Therefore, the market has a great potential for pollen allergic drugs market, which is also going to increase the demand for the product in the forecast period. Thus, increasing prevalence of different kind of allergies is expected to act as driver for the market in the forecast period due to which there will be expected lucrative growth in the market.

  • Impact of pollen allergies on pediatric population

Pollen grains are commonly present in the atmosphere that cause various allergic diseases in North America. Pollen aeroallergens can act as opportunity for the market and propel the market in Mexico. The Impact on paediatric population depends on environmental conditions, changes in the use of soil, different pollen seasons, and annual data for allergists in terms of planning the treatment. The increase in forecasted pollen season longer than usual. The growth of the pollen market can be attributed to the increase in the tree pollen season in the country that elicits allergic reactions such as hay fever and rhinitis in the population which is anticipated to drive the market. Pollen in the atmosphere of city and its impact on the health of the paediatric population.

Hence, prevalence of pollen-induced allergic disease has been increasing with severe symptoms that can be one of the most common health issues affecting adults. Children are the largest age group affected. This is expected to be one of the factors that act as a driver for the Honduras specific pollen allergies market growth in the forecast period.

ホンジュラス特有の花粉アレルギー市場

Opportunity

  •  Increase in the environmental pollution

Common air pollutants, such as ozone, sulphur dioxide, and nitrogen dioxide probably act more as irritants than as promoters of sensitization. These pollutants have been shown to be hazardous to adults and children with asthma. Recent studies suggest that prematurely born children are more sensitive to the respiratory effects of outdoor pollution.

Thus, pollution and allergies go hand-in-hand, worsening air and water pollution enables various heavy metals and non-metals an opportunity to come in close contact with skin and respiratory system thus causing allergies. This is increasing the demand for allergy medications.

The increasing air pollution along with water population is expected to increase the prevalence of respiratory and skin allergies, which is expected to increase the demand for the product used for allergy hence it is considered as opportunity for the market.

Restraint/Challenge

  • Side effects associated with the use of drugs

Sometimes drugs have some kind of side effects or adverse effects among the population. The treatment of allergic response is a multi-drugs therapy, which has a greater chance of compatibility issue, which can cause the condition to get worse. Corticosteroids are known to lower the resistance to infection, which can make it harder to treat. It induced osteoporosis, steroids induced myopathy, and osteonecrosis are some of the disorders that are seen among those that use corticosteroids. Systemic administration of these drugs are known to increase the fasting blood glucose level, which make it vulnerable for the diabetic patients to use these therapies during allergic reaction, hence limiting the market growth.

Drowsiness, Headache, dry mouth, throat, and/or nose, stomach pain, nausea, mucus thickening, and increased appetite/weight gain are some of the side effects induced in the patient taking anti-histaminic. Among all, the drug induced diseases are mostly seen among those that use corticosteroids therapy for longer period of time. These side effects of the drug is expected to limit the use of drugs hence act as restraint for the growth of the Honduras specific pollen allergies market in the forecast period.

Post COVID-19 Impact on pollen allergies market

The COVID-19 has positively affected in the growth of the market. As there is rise in the demand for products is wide in the region. People have become more health conscious as there is prevalence of various diseases in the region which is also rising. Complications of other allergies due to aggravation are often seen and have become a problem.Hence the COVID-19 has impacted positively on this market.

Recent Developments

  • In July 2021, Prestige Consumer Healthcare announced that the company has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company’s manufacturing capacity in the U.S. and help in revenue generation.
  • In September 2021, EUROIMMUN Medizinische Labordiagnostika AG and Immunodiagnostic Systems (IDS) partnership to cooperate in the fields of research and development, production as well as distribution, and this will help to grow the business and generate revenue.

Honduras Specific Pollen Allergies Market Scope

Honduras specific pollen allergies market is categorized into five notable segments which are based on drug type, diagnostic test, product, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Drug Type

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Anticholinergics
  • Others

Based on drug type, the market is segmented into antihistamines, corticosteroids, decongestants, anticholinergics and others.

Diagnostic Test

  • In Vivo Test
  • In Vitro Test

Based on diagnostic test, the market is segmented into in vivo test and in vitro test.

Product

  • Instruments
  • Reagents and Kits
  • Others

Based on product, the market is segmented into in instruments, reagents and kits, and others

End User

  • Hospitals
  • Diagnostics Laboratories
  • Academic and Research Institutes
  • Others

Based on end user, the market is segmented into hospitals, diagnostics laboratories, academic and research institutes, and others.

Distribution Channel

  • Direct Tender
  • Retail Sales

特定の花粉アレルギー市場

Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and others.

Honduras Specific Pollen Allergies Market Regional Analysis/Insights

Honduras specific pollen allergies market is analyzed and market size insights and trends are provided by drug type, diagnostic test, product, end user and distribution channel as referenced above.

The country covered in the Honduras specific pollen allergies report is Honduras.

Honduras specific pollen allergies market is expected to grow due to the rise in incidence of prevalence of allergic diseases. It shows the increase in pollen season longer than usual. The growth of the pollen market can be attributed to the increase in the tree pollen season in the country that elicits allergic reactions such as hay fever and rhinitis in the population which is anticipated to drive the market. Moreover, rising healthcare expenditure and growth of pharmaceutical market is also expected to propel the growth of the market.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Honduras Specific Pollen Allergies Market Share Analysis

Honduras specific pollen allergies market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Honduras specific pollen allergies market.

この市場で活動している主要企業としては、Siemens Healthcare GmbH、Sanofi、bioMérieux SA、GlaxoSmithKline plc.、Minaris Medical America, Inc.、Quest Diagnostics Incorporated、Circassia、Alcon Inc.、Thermo Fisher Scientific Inc.、Johnson & Johnson SA de CV、Lincoln Diagnostics, Inc.、EUROIMMUN Medizinische Labordiagnostika AG、Bayer Pharmaceuticals、Prestige Consumer Healthcare Inc.、 CINFA LABORATORIES、Perrigo Company plc. などが挙げられます。

研究方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。さらに、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これとは別に、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、ホンジュラス対国、ベンダー シェア分析が含まれます。さらに問い合わせる場合は、アナリストへの電話をリクエストしてください。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF HONDURAS SPECIFIC POLLEN ALLERGIES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES MODEL

4.3 CURRENT PATENTS THAT CAN BE USED IN ALLOPATHIC MEDICINES IN MEXICO-

4.4 INVENTION PATENT-

4.5 COUNTRY LEVEL ANALYSIS

5 REGULATIONS

5.1 HONDURAS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASE IN PREVALENCE OF ALLERGIC DISORDER

6.1.2 WIDE RANGE OF PRODUCT PORTFOLIOS OFFERED BY MAJOR PLAYER

6.1.3 IMPACT OF POLLEN ALLERGIES ON PAEDIATRICS POPULATION

6.1.4 HEALTH SECTOR REFORM AND EXPANSION OF PROGRAMMES TO BOOST HEALTHCARE SPENDING

6.2 RESTRAINTS

6.2.1 SIDE EFFECTS ASSOCIATED WITH THE USE OF DRUGS

6.2.2 INCREASE IN TREND OF USING HOME REMEDIES/PHYTOCHEMICALS

6.3 OPPORTUNITIES

6.3.1 INCREASE IN THE ENVIRONMENTAL POLLUTION

6.3.2 AWARENESS OF THE USE OF OTC PRODUCTS

6.3.3 RELAXATION OF RULES ON DIRECT-TO-CONSUMER ADVERTISING

6.4 CHALLENGES

6.4.1 INCREASE IN ABUSE POTENTIAL

6.4.2 INTELLECTUAL PROPERTY RIGHTS LAW

7 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE

7.1 OVERVIEW

7.2 ANTIHISTAMINE

7.2.1 ANTIHISTAMINE, BY DRUG TYPE

7.2.2 LEVOCETIRIZINE

7.2.3 CETIRIZINE

7.2.4 LORATIDINE

7.2.5 DIPHENHYDRAMINE

7.2.6 CHLORPHENIRAMINE

7.2.7 FEXOFENADINE

7.3 CORTICOSTEROIDS

7.3.1 FLUTICASONE PROPIONATE

7.3.2 TRIAMCINOLONE/TRIAMCINOLONE ACETONOID

7.3.3 CROMOLYN SODIUM

7.3.4 OTHERS

7.4 DECONGESTANTS

7.4.1 DECONGESTANTS, BY DRUG TYPE

7.4.2 PSEUDOEPHEDRINE

7.4.3 PHENYLEPHRINE

7.4.4 OXYMETAZOLINE

7.4.5 OTHERS

7.5 ANTICHOLINERGICS

7.5.1 ANTICHOLINERGICS, BY DRUG TYPE

7.5.2 IPRATROPIUM BROMIDE

7.5.3 OTHERS

7.6 OTHERS

8 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS

8.1 OVERVIEW

8.2 INSTRUMENTS

8.2.1 IMMUNO ASSAY ANALYZER

8.2.2 PRODUCTS, BY IMMUNOASSAY ANALYZER

8.3 RADIO IMMUNO ASSAY (RIA)

8.4 COUNTING IMMUNO ASSAY (CIA)

8.5 ENZYME LINKED IMMUNO-SORBENT ASSAYS (ELISA)

8.6 FLUOROIMMNOASSAY (FIA)

8.7 CHEMILUMINESCENCE ASSAY

8.7.1 LUMINOMETERS

8.8 REAGENTS AND KITS

8.9 OTHERS

9 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST

9.1 OVERVIEW

9.2 IN VIVO TEST

9.2.1 IN VIVO TEST, BY DIAGNOSTIC TEST

9.2.2 SKIN PRICK

9.2.2.1 SKIN PRICK, BY DIAGNOSTIC TEST

9.2.2.2 GREER PRICK

9.2.3 THE STELLAR POINT

9.2.4 PHAZET

9.2.5 BIFURCATED SMALLPOX VACCINATION TEST

9.2.6 23G INTRAVENOUS NEEDLE

9.2.7 OTHERS

9.2.8 PATCH TEST

9.2.9 INTRADERMAL TEST

9.3 IN VITRO TEST

9.3.1 IN VITRO TEST, BY DIAGNOSTIC TEST

9.3.2 SERUM SPECIFIC IGE ASSAY

9.3.3 TOTAL IGE ASSAY

9.3.4 BASOPHIL ACTIVATION TEST

10 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 DIAGNOSTICS LABORATORIES

10.4 ACADEMIC AND RESEARCH INSTITUTES

10.5 OTHERS

11 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

11.3.1 RETAIL SALES, BY TYPE

11.3.2 HOSPITAL PHARMACY

11.3.3 RETAIL PHARMACY

11.3.4 ONLINE PHARMACY

12 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: HONDURAS SPECIFIC POLLEN ALLERGIES MARKET

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 GLAXOSMITHKLINE PLC

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.2 JOHNSON & JOHNSON SERVICES, INC

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENTS

14.3 PERRIGO COMPANY PLC

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENTS

14.4 SIEMENS HEALTHCARE GMBH

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 THERMO FISHER SCIENTIFIC INC.

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENT

14.6 BAYER AG

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 ALCON INC.

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENTS

14.8 BIOMÉRIEUX, SA.

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENTS

14.9 CINFA LABORATORIES

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.1 CIRCASSIA

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENTS

14.11 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 LINCOLN DIAGNOSTICS, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 MINARIS MEDICAL AMERICA, INC.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 PRESTIGE CONSUMER HEALTHCARE INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENT

14.15 QUEST DIAGNOSTICS INCORPORATED

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 SANOFI

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表のリスト

TABLE 1 LEVOCETIRIZINE / MONTELUKAST- GLENMARK PHARMACEUTICALS LIMITED

TABLE 2 LEVOCETIRIZINE AND MONTELUKAST-

TABLE 3 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 4 HONDURAS ANTIHISTAMINE DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 5 HONDURAS ANTIHISTAMINE DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)

TABLE 6 HONDURAS CORTICOSTEROIDS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 7 HONDURAS CORTICOSTEROID DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)

TABLE 8 HONDURAS DECONGESTANTS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 9 HONDURAS DECONGESTANTS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)

TABLE 10 HONDURAS ANTICHOLINERGIC DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 11 HONDURAS ANTICHOLINERGICS DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (UNITS)

TABLE 12 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2020-2029 (USD MILLION)

TABLE 13 HONDURAS INSTRUMENTS IN SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2020-2029 (USD MILLION)

TABLE 14 HONDURAS IMMUNO ASSAY ANALYZER IN SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2020-2029 (USD MILLION)

TABLE 15 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2020-2029 (USD MILLION)

TABLE 16 HONDURAS IN VIVO TEST IN SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2020-2029 (USD MILLION)

TABLE 17 HONDURAS ANTIHISTAMINE DRUG TYPE IN SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 18 HONDURAS IN VITRO TEST IN SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2020-2029 (USD MILLION)

TABLE 19 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 20 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 21 HONDURAS RETAIL SALES IN SPECIFIC POLLEN ALLERGIES MARKET, BY TYPE, 2020-2029 (USD MILLION)

図表一覧

FIGURE 1 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: SEGMENTATION

FIGURE 2 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: DATA TRIANGULATION

FIGURE 3 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: DROC ANALYSIS

FIGURE 4 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET : COUNTRY VS REGIONAL MARKET ANALYSIS

FIGURE 5 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: SEGMENTATION

FIGURE 11 THE HIGH PREVALENCE OF ALLERGIC RESPONSE AND INCREASING APPROVAL OF NEW PRODUCT IS EXPECTED TO DRIVE THE HONDURAS SPECIFIC POLLEN ALLERGIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 DRUG TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE HONDURAS SPECIFIC POLLEN ALLERGIES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HONDURAS SPECIFIC POLLEN ALLERGIES MARKET

FIGURE 14 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DRUG TYPE, 2021

FIGURE 15 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY PRODUCTS, 2021

FIGURE 16 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DIAGNOSTIC TEST, 2021

FIGURE 17 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY END USER, 2021

FIGURE 18 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET, BY DISTRIBUTION CHANNEL, 2021

FIGURE 19 HONDURAS SPECIFIC POLLEN ALLERGIES MARKET: COMPANY SHARE 2021 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Honduras Specific Pollen Allergies Market is to grow at a CAGR of 5.7% during the forecast by 2029.
The side effects of the drug is expected to limit the use of drugs hence act as restraint for the growth of the Honduras specific pollen allergies market in the forecast period.
The significant factors flourishing the growth of the Honduras Specific Pollen Allergies Market are increasing prevalence of allergic disorder, and Impact of pollen allergies on pediatric population.
The major players operating in the Honduras Specific Pollen Allergies Market are Siemens Healthcare GmbH, Sanofi, bioMérieux SA, GlaxoSmithKline plc., Minaris Medical America, Inc., Quest Diagnostics Incorporated, Circassia, Alcon Inc., Thermo Fisher Scientific Inc., Johnson & Johnson SA de CV, Lincoln Diagnostics, Inc., EUROIMMUN Medizinische Labordiagnostika AG, Bayer Pharmaceuticals, Prestige Consumer Healthcare Inc., CINFA LABORATORIES, Perrigo Company plc., among others.